| Title |
Combined Dacomitinib and Selpercatinib Treatment for a Patient with EGFR-Mutant Non-Small Cell Lung Cancer and Acquired CCDC6-RET Fusion
|
|---|---|
| Published in |
OncoTargets and therapy, June 2024
|
| DOI | 10.2147/ott.s470946 |
| Pubmed ID | |
| Authors |
Cheng-Yin Liu, Chia-Hsin Liu |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 June 2024.
All research outputs
#21,348,077
of 26,206,339 outputs
Outputs from OncoTargets and therapy
#1,613
of 3,023 outputs
Outputs of similar age
#161,077
of 242,930 outputs
Outputs of similar age from OncoTargets and therapy
#2
of 6 outputs
Altmetric has tracked 26,206,339 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,023 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 30th percentile – i.e., 30% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,930 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.